CoreWeave earnings: Jefferies eying founder selling, not profit, as the next catalyst
CoreWeave (NASDAQ:CRWV) is set to report Q2 earnings. Jefferies keeps a Buy rating and $150 price target, saying profitability inflection is still months away, with an EBIT shift expected in Q4 2026. Jefferies cites 3.86+ GW contracted power, backlog and delivery progress, and notes co-founders’ 10b5-1 sales could affect valuation.
How this was made
The 30-second read
Why it matters
The main tradable elements are (1) the expectation for an in-line Q2 print, (2) the timing of the profitability inflection, and (3) the potential for founder 10b5-1 selling plan cancellations at earnings, which could affect supply/demand dynamics.
Market read
This is a pre-earnings positioning piece that can influence how traders frame the upcoming print, especially around margins timing and potential changes to founder selling.
What to watch
The article notes a delayed draw term loan and shorter financing versus customer contract terms; traders may focus on any liquidity or cost-of-capital implications not captured by the margin forecast.
Background
CoreWeave is scheduled to report second-quarter earnings, with Jefferies positioning the quarter as in-line while pushing the major EBIT inflection to Q4 2026.
Ticker impact
Jefferies reiterates Buy and $150 target ahead of CoreWeave’s Q2 earnings, while flagging profitability inflection is still months away.
Near-term reaction likely hinges on whether Q2 is truly in-line and whether management signals any change to founder selling; otherwise the stock may trade as a valuation/backlog story into Q4 2026.
The newest concrete items are the Jefferies expectations (in-line Q2, EBIT inflection in Q4 2026) and the watch item (possible cancellation of founders’ 10b5-1 plans at earnings), which can move sentiment even without a new profit print.
Market effects
Highlights AI compute demand and data-center power-to-capacity conversion as the market’s key operating metric for AI infrastructure names.
No specific regional impact beyond US-listed AI infrastructure demand narrative.
Backlog and capex read-through to hyperscalers (Oracle, Microsoft, Amazon, Alphabet) reinforces global AI infrastructure spending expectations.
Counterpoint
If Q2 EBIT or margins come in below the “in-line” expectation, the delayed profitability timeline could dominate and compress the multiple despite strong backlog.
Key entities
- companyCoreWeave Inc
NASDAQ-listed AI compute infrastructure provider reporting Q2 earnings tonight; Jefferies flags delayed profitability and watches founder 10b5-1 selling plan cancellations.
- analyst_firmJefferies
Maintains Buy rating and $150 price target, while forecasting in-line Q2 and EBIT inflection in Q4 2026.
- executiveBrian Venturo
CoreWeave co-founder and CSO referenced as having sold $1.18B via 10b5-1 plans, with Jefferies noting a slowed pace.
